Key result
ACE inhibitor-induced cough affects ~20% of diabetics, linked to female gender and prolonged use.
Why the study?
ACE inhibitors reduce cardiovascular events and mortality, but cough can lead to poor adherence and increased morbidity; this study sought to determine the prevalence of ACEI-induced cough in diabetic patients.
What is the prevalence and what are the risk factors for ACE inhibitor-induced cough among diabetic patients?
Cross-Sectional (n=100)
No
What is the prevalence and what are the risk factors for ACE inhibitor-induced cough among diabetic patients?
ACE inhibitor-induced cough is common among diabetic patients, affecting 20% of users, with higher risk in females and those with prolonged use.
No takes yet. Share an insight, caveat, or question.
May inform cough monitoring in diabetic ACEI users; hypothesis-generating and requires prospective confirmation before guiding practice.
Abonyi et al. (2023) conducted a cross-sectional in Diabetes mellitus (n=100). ACE inhibitors was evaluated on Prevalence of ACEI-induced cough. ACE inhibitor-induced cough occurred in 20% of diabetic patients, with female gender (p=0.022) and prolonged use (p=0.017) positively correlated with cough.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: